Ohio
Phase 2 colorectal cancer trials in Ohio
11 Phase 2 colorectal cancer studies are recruiting participants at sites in 12 cities across Ohio as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse Ohio by city
Cities with the most studies recruiting right now.
Cleveland
4 studies recruiting.
Columbus
4 studies recruiting.
Cincinnati
3 studies recruiting.
Every Ohio city with a recruiting study
Cleveland (4), Columbus (4), Cincinnati (3), Canton (1), Centerville (1), Colombus (1), Dayton (1), Franklin (1), Greenville (1), Toledo (1), Troy (1), Youngstown (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Ohio
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- Cleveland
- Registry record
- NCT07659795 · updated
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Solstice Oncology, Inc.
- Recruiting in
- Cleveland
- Registry record
- NCT07808151 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Recruiting in
- Canton · Cincinnati · Colombus
- Registry record
- NCT07446322 · updated
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Recruiting in
- Cleveland
- Registry record
- NCT06760819 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Recruiting in
- Centerville · Columbus · Dayton · and 3 more U.S. locations
- Registry record
- NCT05673148 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Cincinnati
- Registry record
- NCT06820463 · updated
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Phase 2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Cincinnati · Columbus
- Registry record
- NCT05489211 · updated
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Jennifer Dorth
- Recruiting in
- Cleveland
- Registry record
- NCT07425054 · updated
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Recruiting in
- Columbus
- Registry record
- NCT06948448 · updated
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
- Phase 2
- Ages 50 and older
- Female participants
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Recruiting in
- Columbus
- Registry record
- NCT07407647 · updated
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- NGM Biopharmaceuticals, Inc
- Recruiting in
- Toledo · Youngstown
- Registry record
- NCT07033026 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Ohio on ClinicalTrials.gov.
Ask about studies in Ohio
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.
Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections